[Pj-015] Japanese Poster Session 015

[Pj-015-3] Protocol for EPI-589 early Phase 2 Investigator-initiated Clinical trial for ALS (EPIC-ALS)

^○Shotaro Haji¹, Koji Fujita¹, Ryosuke Oki¹, Yusuke Osaki¹, Yuki Kanazawa², Yuki Matsumoto³, Atsuko Arisawa⁴, Hisashi Kawai⁵, Yasutaka Sato⁶, Kenta Yagi⁶, Satoshi Sakaguchi⁶, Hiroaki Yanagawa⁶, Tatsuto Hamatani⁷, Seiichi Nagano⁸, Hideki Mochizuki⁸, Naoki Atsuta⁹, Manabu Doyu⁹, Gen Sobue¹⁰, Masafumi Harada³, Yuishin Izumi¹ (1.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 2.Aichi Medical University School of Medicine, 3.Department of Biomedical Information Sciences, Tokushima University Graduate School of Health Sciences, 4.Department of Radiology, Tokushima University Graduate School of Biomedical Sciences, 5.Diagnostic and Interventional Radiology, Osaka University School of Medicine Graduate School of Medicine, 6.Department of Radiology, Aichi Medical University School of Medicine, 7.Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 8.Sumitomo Dainippon Pharma Co., Ltd., 9.Department of Neurotherapeutics, Osaka University Graduate School of Medicine, 10.Department of Neurology, Aichi Medical University School of Medicine)